Aim for lean proteins, vegetables, and complex carbohydrates
Challenges and strategies for moving patients to injectable medications
No single peptide is a complete solution on its own
Because semaglutide and tirzepatide are large peptide molecules, theoretical transfer is likely minimal, but definitive data does not exist
By combining science-backed medication with compassionate, ongoing medical oversight, MEDVi delivers a balanced, evidence-based solution for patients who have struggled with traditional diets and exercise alone
Safety Concerns with Compounded GLP-1s Risks that have been reported Research using the FDAs adverse event database has found that reports involving compounded GLP-1 drugs show higher odds of: Stomach pain, nausea, and diarrhea Gallbladder problems such as cholecystitis (inflamed gallbladder) Medication preparation and prescribing errors Product contamination and compounding/manufacturing problems Hospitalization linked to these issues This same analysis found that compounded products had much higher reporting odds for preparation errors and contamination compared with non-compounded GLP-1s
